EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Altered gut microbiome in convalescent patients with coronavirus disease 2019

Kyoung Hwa Lee, Yeong Ouk Kim, So Hee Dho, Jen J H Yong, Hyun-Seok Oh, Je Hee Lee, Seung-Jo Yang, Inseong Cha, Jongsik Chun, Eun Hwa Lee, Su Jin Jeong, Wonjin Woo und 6 weitere

Frontiers in Cellular and Infection Microbiology · 2024

DOI: 10.3389/fcimb.2024.1455295 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Kyoung Hwa Lee und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: COVID-19, Gastrointestinal Microbiome, Feces, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Coronavirus disease 2019 (COVID-19) alters the gut microbiome. This study aimed to assess the association between the disease severity of COVID-19 and changes in stool microbes through a seven-month follow-up of stool collection.

Methods

We conducted a multicentre, prospective longitudinal study of 58 COVID-19 patients and 116 uninfected controls. Differences in the gut microbiota were analysed using 16S ribosomal RNA sequencing. The first stool samples were collected at an early convalescent phase of COVID-19, and the second sample was collected at least seven months after COVID-19 infection. Results and discussion At the order level, Eubacteriales and Bifidobacteriales decreased, while Bacteroidales and Burkholderiales increased in the COVID-19 group compared to the controls. Alpha diversity also decreased in COVID-19 patients compared to controls, with imperfect recovery of the gut microbiome after seven months. The compositional change in the gut microbiome between the early and late convalescent phases was largest in the moderate and severe groups. The severity of COVID-19 was the most influential clinical variable for microbiome composition (Sum of Sqs = 0.686, P = 0.006), and its effect persisted even after partialling out other effects such as antibiotic use and age. Thus, our study indicates a possible interaction between respiratory viral infection and the composition of the gut microbiota community, warranting future mechanistic and prospective longitudinal studies. Additionally, we were able to detect microbiome changes in patients who were re-infected with SARS-CoV-2. Notably, the dominant bacteria in the re-infected group were Lachnospiraceae and Faecalimonas umbilicata , compared to the one-time infected group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Gastrointestinal MicrobiomeFecesSARS-CoV-2RNA, Ribosomal, 16SHumansMaleFemaleMiddle AgedProspective StudiesLongitudinal StudiesAdultSeverity of Illness IndexConvalescenceBacteriaAged

Stichwörter der Autor:innen

SARS-CoV-2convalescent patientsmetagenomicsseverity of coronavirus disease 2019 (COVID-19)stool microbiome

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • CJ Bioscience, Inc., Seoul, Republic of Korea.
  • Interdisciplinary Program in Bioinformatics, Seoul National University, Seoul, Republic of Korea.
  • Department of Biomedical Sciences, Graduate School of Medical Science, Brain Korea 21 Project, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, United States.
  • Division of Infectious Diseases, Department of Internal Medicine, Seoul Medical Center, Seoul, Republic of Korea.

Zitieren

APA

Lee, K. H., Kim, Y. O., Dho, S. H., Yong, J. J. H., Oh, H. S., Lee, J. H., Yang, S. J., Cha, I., Chun, J., Lee, E. H., Jeong, S. J., Woo, W., Choi, J. P., Han, S. H., Choi, G. B., Huh, J. R., Kim, L. K., & Song, Y. G. (2024). Altered gut microbiome in convalescent patients with coronavirus disease 2019. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1455295

Vancouver

Lee KH, Kim YO, Dho SH, Yong JJH, Oh HS, Lee JH, et al. Altered gut microbiome in convalescent patients with coronavirus disease 2019. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1455295

BibTeX
@article{Lee2024,
  author = {Lee, Kyoung Hwa and Kim, Yeong Ouk and Dho, So Hee and Yong, Jen J H and Oh, Hyun-Seok and Lee, Je Hee and Yang, Seung-Jo and Cha, Inseong and Chun, Jongsik and Lee, Eun Hwa and Jeong, Su Jin and Woo, Wonjin and Choi, Jae-Phil and Han, Sang Hoon and Choi, Gloria B and Huh, Jun R and Kim, Lark Kyun and Song, Young Goo},
  title = {Altered gut microbiome in convalescent patients with coronavirus disease 2019},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  doi = {10.3389/fcimb.2024.1455295}
}
Kostenlos starten →